(Q40218427)

18 September 2017

A novel DNA vaccine encoding PDGFRbeta suppresses growth and dissemination of murine colon, lung and breast carcinoma (English)

1 reference

18 September 2017

Charles D Kaplan

1

1 reference

18 September 2017

Jörg A Krüger

2

1 reference

18 September 2017

He Zhou

3

1 reference

18 September 2017

Yunping Luo

4

1 reference

18 September 2017

Rong Xiang

5

1 reference

18 September 2017

Ralph A Reisfeld

6

1 reference

18 September 2017

language of work or name

English

0 references

publication date

5 June 2006

1 reference

18 September 2017

1 reference

18 September 2017

24

1 reference

18 September 2017

6994-7002

1 reference

18 September 2017

47-48

1 reference

Antiangiogenic tumour therapy: will it work?

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Antiangiogenic gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Cancer invasion and metastasis: positive and negative regulatory elements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Mouse fibroblast-activation protein--conserved Fap gene organization and biochemical function as a serine protease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Involvement of platelet-derived growth factor in disease: development of specific antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Tissue localization of beta receptors for platelet-derived growth factor and platelet-derived growth factor B chain during wound repair in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Expression of tyrosine kinases in human malignancies as potential targets for kinase-specific inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

PDGFRbeta+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Chimaeric analysis reveals role of Pdgf receptors in all muscle lineages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Endothelial/pericyte interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Vascular endothelial growth factor (VEGF) and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

VEGF receptor signaling in tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Stable expression of angiopoietin-1 and other markers by cultured pericytes: phenotypic similarities to a subpopulation of cells in maturing vessels during later stages of angiogenesis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Angiopoietin 1, PDGF-B, and TGF-beta gene regulation in endothelial cell and smooth muscle cell interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Disordered cellular migration and angiogenesis in cd39-null mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.071

10.1016/J.VACCINE.2006.04.071

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference